These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3891467)

  • 1. Abnormal glucose modulation of islet A- and B-cell responses to arginine in non-insulin-dependent diabetes mellitus.
    Dimitriadis GD; Pehling GB; Gerich JE
    Diabetes; 1985 Jun; 34(6):541-7. PubMed ID: 3891467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDM.
    Rachman J; Gribble FM; Barrow BA; Levy JC; Buchanan KD; Turner RC
    Diabetes; 1996 Nov; 45(11):1524-30. PubMed ID: 8866556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus.
    Ward WK; Bolgiano DC; McKnight B; Halter JB; Porte D
    J Clin Invest; 1984 Oct; 74(4):1318-28. PubMed ID: 6384269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of high carbohydrate intake on hyperglycemia, islet function, and plasma lipoproteins in NIDDM.
    Garg A; Grundy SM; Koffler M
    Diabetes Care; 1992 Nov; 15(11):1572-80. PubMed ID: 1468287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of glucagon-like peptide-1 on islet function and insulin sensitivity in noninsulin-dependent diabetes mellitus.
    Ahrén B; Larsson H; Holst JJ
    J Clin Endocrinol Metab; 1997 Feb; 82(2):473-8. PubMed ID: 9024239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology of insulin secretion in diabetes mellitus.
    Ward WK; Beard JC; Halter JB; Porte D
    Adv Exp Med Biol; 1985; 189():137-58. PubMed ID: 3898762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
    Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion.
    Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P; Gerich JE
    Diabetes; 1983 Feb; 32(2):134-41. PubMed ID: 6337896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose.
    Greenbaum CJ; Prigeon RL; D'Alessio DA
    Diabetes; 2002 Apr; 51(4):951-7. PubMed ID: 11916912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective glucose counterregulation after subcutaneous insulin in noninsulin-dependent diabetes mellitus. Paradoxical suppression of glucose utilization and lack of compensatory increase in glucose production, roles of insulin resistance, abnormal neuroendocrine responses, and islet paracrine interactions.
    Bolli GB; Tsalikian E; Haymond MW; Cryer PE; Gerich JE
    J Clin Invest; 1984 Jun; 73(6):1532-41. PubMed ID: 6373827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic alpha-cell function in diabetic hemochromatotic subjects.
    Nelson RL; Baldus WP; Rubenstein AH; Go VL; Service FJ
    J Clin Endocrinol Metab; 1979 Sep; 49(3):412-6. PubMed ID: 381322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon-like peptide 1 improves the ability of the beta-cell to sense and respond to glucose in subjects with impaired glucose tolerance.
    Byrne MM; Gliem K; Wank U; Arnold R; Katschinski M; Polonsky KS; Göke B
    Diabetes; 1998 Aug; 47(8):1259-65. PubMed ID: 9703326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of epinephrine on pancreatic beta-cell and alpha-cell function in patients with NIDDM.
    Ortiz-Alonso FJ; Herman WH; Zobel DL; Perry TJ; Smith MJ; Halter JB
    Diabetes; 1991 Sep; 40(9):1194-202. PubMed ID: 1936624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose modulation of insulin and glucagon secretion in nondiabetic and diabetic man.
    Hollander PM; Asplin CM; Palmer JP
    Diabetes; 1982 Jun; 31(6 Pt 1):489-95. PubMed ID: 6759265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative and qualitative differences in basal and glucose- and arginine-stimulated insulin secretion in healthy subjects and different stages of NIDDM.
    Ratheiser K; Reitgruber W; Komjati M; Bratusch-Marrain P; Vierhapper H; Waldhäusl WK
    Acta Diabetol Lat; 1990; 27(3):197-213. PubMed ID: 2075783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of family history of diabetes on the assessment of beta-cell function.
    Alford FP; Henriksen JE; Rantzau C; Vaag A; Hew LF; Ward GM; Beck-Nielsen H
    Metabolism; 1998 May; 47(5):522-8. PubMed ID: 9591741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of beta-cell secretory capacity using glucagon-like peptide 1.
    Vilsbøll T; Toft-Nielsen MB; Krarup T; Madsbad S; Dinesen B; Holst JJ
    Diabetes Care; 2000 Jun; 23(6):807-12. PubMed ID: 10841001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examining the effects of hyperglycemia on pancreatic endocrine function in humans: evidence for in vivo glucotoxicity.
    Solomon TP; Knudsen SH; Karstoft K; Winding K; Holst JJ; Pedersen BK
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4682-91. PubMed ID: 23043193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Islet hormonal regulation of glucose turnover during exercise in type 1 diabetes.
    Shilo S; Sotsky M; Shamoon H
    J Clin Endocrinol Metab; 1990 Jan; 70(1):162-72. PubMed ID: 1967178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased epinephrine and skeletal muscle responses to hypoglycemia in non-insulin-dependent diabetes mellitus.
    Shamoon H; Friedman S; Canton C; Zacharowicz L; Hu M; Rossetti L
    J Clin Invest; 1994 Jun; 93(6):2562-71. PubMed ID: 8200993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.